Rare diseases
Investigational molecules
Locations
147 conditions with trials, the busiest first
548 trials across Europe, recruiting first
A Randomized Controlled Trial of Cannabidiol vs Placebo Augmentation in Patients with First Episode Psychosis
AustriaEffect of Stopping Ethinylestradiol/Levonorgestrel Contraceptive on Mood and Memory in Adults with Major Depressive Disorder on Antidepressant Combination
DenmarkTirzepatide versus CPAP and Lifestyle Modification for Obstructive Sleep Apnea in Adults ≥ 65 years with Overweight or Obesity – Randomized Trial
SpainEffect of Hydroxocobalamin Acetate, Thiamine Hydrochloride, and Pyridoxine Hydrochloride Supplementation on Brain Injury in Outpatients with Alcohol Use Disorder
FranceEvaluation of Propranolol‑Enhanced Traumatic Memory Reactivation for Post‑Traumatic Stress Disorder in Women Victims of Violence
FranceLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
FinlandA Randomized Double‑Blind Placebo‑Controlled Study of TAK‑360 in Adults with Narcolepsy with Cataplexy (Type 1)
FranceFeasibility and Safety of PEX010 Psilocybin Capsules (5 mg and 25 mg) in Military Veterans with Posttraumatic Stress Disorder
The NetherlandsCannabidiol for Alcohol Dependence in Adults Seeking Abstinence: A Phase II Placebo‑Controlled Trial
SpainLong-term safety and outcomes of repeated rituximab in adults with schizophrenia spectrum disorder
SwedenOxytocin Nasal Spray for Reducing Cravings and Preventing Relapse in Adults with Substance Use Disorder
ItalyMicrodosing lysergide (20 µg) to improve symptoms, emotion regulation and sleep in adults with ADHD
The NetherlandsThe therapies tested most often in Psychiatric disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
